Nectin Therapeutics vs Upstream Bio

Nectin Therapeutics vs Upstream Bio, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nectin Therapeutics is on 50/100 and Upstream Bio on 61/100.

Nectin Therapeutics logo
Nectin TherapeuticsBiotech company developing next-generation immunotherapy agents to unlock the immune system.
Try Nectin Therapeutics
Upstream Bio logo
Upstream BioClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Try Upstream Bio

Where each one leads

Nectin Therapeutics

Leads on none of the measures we hold for both companies.

Upstream Bio

  • our overall score: 61/100 against 50/100
  • agent readiness: 39/100 against 21/100
  • domain rating: 32/100 against 23/100
  • headcount: 75 against 11
  • headcount growth: +43.4% against +2.9%
  • funding raised: $400M against $64.1M
  • LinkedIn following: 11,799 against 1,591

At a glance

MeasureNectin TherapeuticsUpstream Bio
What it isBiotech company developing next-generation immunotherapy agents to unlock the immune system.Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
CategoryLife Sciences, Immunotherapy, Immunology, CancerLife Sciences, Therapeutics, Biotech, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20162021
HeadquartersNot publishedWaltham, United States
StatusActiveActive

Size, funding and growth

MeasureNectin TherapeuticsUpstream Bio
Employees1175
Headcount growthLast 12 months+2.9%+43.4%
Total funding$64.1M$400M
Latest roundSeries CSeries B
LinkedIn followers1,59111,799

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureNectin TherapeuticsUpstream Bio
StartupHub scoreOur 0-100 rating50/10061/100
Traction50/10059/100
Team30/10070/100
Search visibility30/10037/100
Quality58/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)F (39/100)
Domain ratingLink authority, 0-10023/10032/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureNectin TherapeuticsUpstream Bio
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJqueryJquery, Bootstrap
AnalyticsGoogle Analytics 4, SegmentGoogle Tag Manager

Nectin Therapeutics vs Upstream Bio: common questions

Which is better, Nectin Therapeutics or Upstream Bio?

On our 0-100 score Upstream Bio rates higher (61/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.

How do Nectin Therapeutics and Upstream Bio compare on the numbers?

Upstream Bio leads on our overall score (61/100 against 50/100), agent readiness (39/100 against 21/100), domain rating (32/100 against 23/100), headcount (75 against 11), headcount growth (+43.4% against +2.9%), funding raised ($400M against $64.1M), LinkedIn following (11,799 against 1,591).

Read the full Nectin Therapeutics review and pricing or the Upstream Bio review and pricing. You can also browse other Nectin Therapeutics alternatives we track.